ESR1 and breast carcinoma: These concerns exist because of evidence showing that isoflavones bind and transactivate estrogen receptors (ERs) [7,8], induce proliferation and estrogenic markers in MCF-7 cells, an ER positive (ER+) breast cancer cell line [9-14], and elicit estrogenic effects in rodent reproductive tissues [15,16].